Dennis L. Cooper MD

Professor of Medicine (Hematology)

Clinical Interests

Bone marrow transplant (including stem cell support); cutaneous T-cell lymphoma (CTCL); head and neck cancer; lymphoma; Hodgkin's disease; multiple myeloma


Board Certifications

1983
Internal Medicine, Board Certified
1986
Medical Oncology, Board Certified

Patient Care Locations

dennis_cooperfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Graft Versus Host Disease, Myelodysplastic Syndromes, Leukemia, not otherwise specified, and Non-Hodgkin's LymphomaA Multicenter, Phase II Study of Selective Depletion of CD45RA+ T Cells from Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Hepatic Veno-Occlusive Disease, Hodgkin's Lymphoma, Leukemia, not otherwise specified, Multiple Myeloma, and Non-Hodgkin's LymphomaDefibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study
Limited-stage Diffuse Large B-Cell Lymphoma and Non-Hodgkin's LymphomaA Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Leukemia, not otherwise specified and Myeloid and Monocytic LeukemiaA Phase 1-2, Dose Escalation, Multicenter Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects with Intermediate or High-Risk Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Lymphoid LeukemiaA Phase 1/2 Study of ISIS 481464, an Antisense Oligonucleotide Inhibitor of STAT3, Administered to Patients with Advanced Cancers

More Clinical Trials...

Edit Profile